Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes.
The small heat shock protein HSP20 is known to be cardioprotective during times of stress and the mechanism underlying its protective abilities depends on its phosphorylation on Ser16 by PKA (protein kinase A). Although the external stimuli that trigger Ser16 phosphorylation have been well studied,...
Huvudupphovsmän: | Sin, Y, Edwards, H, Li, X, Day, J, Christian, F, Dunlop, A, Adams, DR, Zaccolo, M, Houslay, MD, Baillie, G |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2011
|
Liknande verk
Liknande verk
-
Cyclic nucleotide phosphodiesterases in health and disease /
av: Beavo, Joe, et al.
Publicerad: (2007) -
Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target.
av: Thavy Long, et al.
Publicerad: (2017-07-01) -
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
av: Jonathan E. Phillips
Publicerad: (2020-03-01) -
TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.
av: Abrahamsen, H, et al.
Publicerad: (2004) -
Targeted disruption of the heat shock protein 20–phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy
av: Tamara P. Martin, et al.
Publicerad: (2014-01-01)